GeneDx Holdings Corp. (WGS) stock analysis
WGS · GeneDx Holdings Corp.
Latest recorded price: USD 51.02
Sector and industry: Healthcare · Diagnostics & Research
Fiscal 2025 figures: revenue growth 22.1%, free cash flow margin 3.3%, ROIC -3.6%. The model flags 1 risk signal for this company.
Similar companies in Healthcare
- Agilent Technologies, Inc. Common Stock (A)
- Adaptive Biotechnologies Corporation (ADPT)
- CareDx, Inc. - Common Stock (CDNA)
- Charles River Laboratories International, Inc. (CRL)
- Castle Biosciences, Inc. (CSTL)
- Quest Diagnostics Incorporated Common Stock (DGX)
- Danaher Corporation Common Stock (DHR)
- Guardant Health, Inc. (GH)